Evidence map›Paper›PMID 29119972›Full record

ReviewNature reviews. Disease primers2017

Rotavirus infection.

Sue E Crawford, Sasirekha Ramani, Jacqueline E Tate, Umesh D Parashar, Lennart Svensson, Marie Hagbom, Manuel A Franco, Harry B Greenberg, Miguel O'Ryan, Gagandeep Kang and 2 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Nature reviews. Disease primers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 385 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
385citing papers in PubMed, 2 pooled it
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

385 citing papers in PubMed, 2 syntheses or guidelines pooled it, 672 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Campylobacter jejuni bacteremia in a neutropenic child with B-Cell acute lymphoblastic leukemia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

325 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 6 countries.

Sue E CrawfordDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, MS: BCM-385, Houston, Texas 77030, USA.
Sasirekha RamaniDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, MS: BCM-385, Houston, Texas 77030, USA.
Jacqueline E TateDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Umesh D ParasharDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, United States Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Lennart SvenssonDivision of Molecular Virology, Medical Faculty, Linköping University, Linköping, Sweden.
Marie HagbomDivision of Molecular Virology, Medical Faculty, Linköping University, Linköping, Sweden.
Manuel A FrancoInstituto de Genetica Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia.
Harry B GreenbergDepartment of Microbiology and Immunology, Stanford University, Stanford, California, USA.
Miguel O'RyanMicrobiology and Mycology Program, Institute of Biomedical Sciences, and Millennium Institute of Immunology and Immunotherapy, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Gagandeep KangTranslational Health and Science Technology Institute, Faridabad, India.
Ulrich DesselbergerDepartment of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Mary K EstesDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, MS: BCM-385, Houston, Texas 77030, USA.
Baylor College of Medicine · USCenters for Disease Control and Prevention · USAddenbrooke's Hospital · GBChristian Medical College & Hospital · INKarolinska Institutet · SELinköping University · SEPontificia Universidad Javeriana · COStanford University · USUniversity of Chile · CL

Funding

Novel Platforms for Human Intestinal Enteroids: Matrix, Mechanics, and TopographyU19AI116497 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BLUTT, SARAH E · 2015 to 2025
$13.2M
Regulation of Rotavirus ReplicationR01AI080656 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI Sue Ellen Crawford, Mary Kolb Estes · 2009 to 2026
$7.9M
Intestinal and Milk Glycan Expression in Restriction of Neonatal InfectionR01AI105101 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI ESTES, MARY KOLB · 2013 to 2016
$1.5M
NIAID NIH HHS R01 AI080656NIAID NIH HHS R01 AI105101NIAID NIH HHS U19 AI116497
6 · The paper itself

Abstract

Rotavirus infections are a leading cause of severe, dehydrating gastroenteritis in children <5 years of age. Despite the global introduction of vaccinations for rotavirus over a decade ago, rotavirus infections still result in >200,000 deaths annually, mostly in low-income countries. Rotavirus primarily infects enterocytes and induces diarrhoea through the destruction of absorptive enterocytes (leading to malabsorption), intestinal secretion stimulated by rotavirus non-structural protein 4 and activation of the enteric nervous system. In addition, rotavirus infections can lead to antigenaemia (which is associated with more severe manifestations of acute gastroenteritis) and viraemia, and rotavirus can replicate in systemic sites, although this is limited. Reinfections with rotavirus are common throughout life, although the disease severity is reduced with repeat infections. The immune correlates of protection against rotavirus reinfection and recovery from infection are poorly understood, although rotavirus-specific immunoglobulin A has a role in both aspects. The management of rotavirus infection focuses on the prevention and treatment of dehydration, although the use of antiviral and anti-emetic drugs can be indicated in some cases.

Indexed as

Rotavirus InfectionsHumans

Identifiers

PMID29119972
PMCPMC5858916
OpenAlexW4211219645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.